Amsacrine - Wikipedia
Amsacrine (synonyms: m-AMSA, acridinyl anisidide) is an antineoplastic agent. It has been used in acute lymphoblastic leukemia ... Ketron AC, Denny WA, Graves DE, Osheroff N (February 2012). "Amsacrine as a Topoisomerase II Poison: Importance of Drug-DNA ... Horstmann MA, Hassenpflug WA, zur Stadt U, Escherich G, Janka G, Kabisch H (December 2005). "Amsacrine combined with etoposide ... Amsacrine also expresses topoisomerase inhibitor activity, specifically inhibiting topoisomerase II. In contrast, the ...
Amsacrine - Janusinfo.se
Amsacrine (Toxic Effects in Humans- 3) - PT Master Guide
Amsacrine (Toxic Effects in Humans- 2) → Amsacrine (Toxic Effects in Humans- 4) ... Amsacrine (Toxic Effects in Humans- 3). In this article we will discuss Amsacrine (Toxic Effects in Humans- 3) ... In this article, we will discuss Amsacrine (Toxic Effects in Humans- 3). So, lets get started. ... Nausea, vomiting and mucositis are common after administration of amsacrine. Diarrhoea occurs in about 10-20% of patients ( ...
Acyclovir Monograph for Professionals - Drugs.com
High-resolution mapping of mammalian genes by in situ hybridization to free chromatin
Melanoma - HealthWell Foundation
Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patients diagnosis, which must be verified by a physician, nurse practitioner, or physician assistants signature. The patient must receive treatment in the United States.. ...
Pediatric Dilated Cardiomyopathy: Practice Essentials, Background, Pathophysiology
Idiopathic dilated cardiomyopathy (DCM) refers to congestive cardiac failure secondary to dilatation and systolic dysfunction (with or without diastolic dysfunction) of the ventricles (predominantly the left ventricle) in the absence of congenital, valvular, or coronary artery disease or any systemic disease known to cause myocardial dysfunct...
Heads of Medicines Agencies: Outcome of informal PSUR worksharing procedures
Acute promyelocytic leukemia: where did we start, where are we now, and the future | Blood Cancer Journal
Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy. Blood 1984; 63: 211-212. ... amsacrine and prednisone. Cunningham et al.15 reported a median survival of 6 weeks following relapse. A variety of reinduction ... Treatment of recurrent promyelocytic leukemia with a combination regimen utilizing amsacrine, cytosine arabinoside and 6- ...
DailyMed - CEFTRIAXONE SODIUM injection, powder, for solution
Pegcetacoplan: Uses, Interactions, Mechanism of Action | DrugBank Online
MUTAMYCIN - biam2
Clofarabine
retinoids (Alitretinoin, Tretinoin) - Altretamine, Amsacrine, Anagrelide, Arsenic trioxide, Asparaginase (Pegaspargase), ...
Cancer biochemistry biophysics-各期论文-万方医学网
Monographie - Lorazepam - Stabilis 4.0
UKE - Physician - Martin Horstmann
Zovirax (acyclovir) dosing, indications, interactions, adverse effects, and more
Index by author - December 01, 1999, 56 (6) | Molecular Pharmacology
Potential Mechanisms Governing Sensitivity of HL-60 Cells to Amsacrine and Etoposide Dale R. Grabowski, Katherine A. Holmes, ... Potential Mechanisms Governing Sensitivity of HL-60 Cells to Amsacrine and Etoposide Dale R. Grabowski, Katherine A. Holmes, ... Potential Mechanisms Governing Sensitivity of HL-60 Cells to Amsacrine and Etoposide Dale R. Grabowski, Katherine A. Holmes, ... Potential Mechanisms Governing Sensitivity of HL-60 Cells to Amsacrine and Etoposide Dale R. Grabowski, Katherine A. Holmes, ...
Drug Eruptions: Practice Essentials, Background, Pathophysiology
38] - Amsacrine, bleomycin, busulfan, carboplatin, chlorambucil, cisplatin, cyclophosphamide, cytarabine, daunorubicin, ...
US Patent for Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates Patent (Patent # 7,723,485 issued May 25,...
Biblio | StemBook
High-Dose Cytarabine Consolidation With or Without Additional Amsacrine and Mitoxantrone in Acute Myeloid Leukemia: Results of ...